| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |